Selpercatinib in India – Advanced Cancer Treatment for RET Fusion-Positive Tumors

Health7 months ago

Source: Selpercatinib in India – Advanced Cancer Treatment for RET Fusion-Positive Tumors

Selpercatinib 40 & 80 mg in India is a cutting-edge anticancer medication used for treating RET fusion-positive non-small cell lung cancer (NSCLC) and thyroid cancer, including medullary thyroid carcinoma. Available through Impomed Healthcare, this targeted therapy blocks the RET kinase enzyme, slowing cancer cell growth.